1. 1. Davidson‟s. Principal and practice of medicine. 21th edition. Churchill livin stone publication, 2010, (chapter 17-kidney and urinary tract), P-497.
   2. Sakhuja V, Sud K. End-stage renal disease in India the burden of disease and management issue. Kidney Int 2003;63:S115-S-8.
   3.  Jungers P, Chauveau P, Bandin O. Hyperhomocysteinemia is associated with atherosclerotic occlusive arterial accidents in predialysis chronic renal failure patients. Miner Electrolyte Metab 1997;23:170-3.
   4.  Aghakhani N, Sharif F, Molazem Z, Habibzadeh H. Content analysis and qualitative study of hemodialysis patients, family experience and perceived social support. Iran Red Crescent Med J 2014;16:e13748.
   5.  Murali R, Sathyanarayana D, Muthusethupathy MA. Assessment of quality of life in chronic kidney disease patients using the kidney disease quality of life-short form TM questionnaire in the Indian population: a community-based study. Asian J Pharm Clin Res 2015;8:271-4.
   6.  Kurokawa K, Nangaku M, Saito A, Inagi R, Miyata T. Current issues and future perspectives of chronic renal failure. J Am Soc Nephrol 2002;13:S3–S6. priorities and obstacles. Nephrology (Carlton) 1996;2:65-72
   7. Modi GK, Jha V. The incidence of end-stage renal disease in India: a population-based renal disease in India: a population- based study. Kidney Int 2006;70:2131-3.
   8. Mani MK. The management of end-stage renal disease in India. Artif Organs 1998;22:182-6.
   9. Agarwal R. Hypertension and survival in chronic hemodialysis patients-past lessons and future opportunities. Kidney Int 2005;67:1-13.
   10. Sakhuja V, Jha V, Ghosh AK. Chronic renal failure in India. Nephrol Dial Transplant 1994;9:871-2.
   11.  Kronenberg F. Emerging risk factors and markers of chronic kidney disease progression. Nat Rev Nephrol 2009;5: